NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Investors of record on Friday, January 25th will be given a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a yield of 3.23%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, February, 20th. The pharmacy operator reported $2.14 earnings per share for the quarter, beating the consensus estimate of $2.07 by $0.07. The pharmacy operator earned $54.42 billion during the quarter, compared to analysts' expectations of $53.78 billion. CVS Health had a positive return on equity of 17.49% and a negative net margin of 0.31%. CVS Health's quarterly revenue was up 12.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.92 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of $6.68-6.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.34. CVS Health also updated its FY 2019 guidance to $6.68-6.88 EPS.

17 brokers have issued twelve-month price objectives for CVS Health's shares. Their forecasts range from $68.00 to $100.00. On average, they expect CVS Health's share price to reach $87.25 in the next year. This suggests a possible upside of 40.8% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have been trending somewhat positive on Saturday, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned media coverage about the pharmacy operator a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future.

CVS Health saw a increase in short interest in January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Based on an average daily volume of 9,924,659 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.1% of the company's shares are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), HS SPINCO INC/SH (CVET), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Bank of America (BAC), Johnson & Johnson (JNJ), Cisco Systems (CSCO), General Electric (GE), Alibaba Group (BABA), Intel (INTC), Starbucks (SBUX) and NVIDIA (NVDA).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.12%), Oregon Public Employees Retirement Fund (2.46%), Barrow Hanley Mewhinney & Strauss LLC (1.88%), Northern Trust Corp (1.76%), Geode Capital Management LLC (1.62%) and Bank of New York Mellon Corp (1.43%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Diamond Hill Capital Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $61.95.

CVS Health has a market capitalization of $63.11 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]